Alexander Davis
Psychiatric/Mental Health · Saint Louis, MONPI 1881289510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,193, more than ten times the $17 reported in 2021.
Across 138 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$541
- Supernus Pharmaceuticals, Inc.$462
- Otsuka America Pharmaceutical, Inc.$453
- Alkermes, Inc.$198
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$183
- Teva Pharmaceuticals USA, Inc.$164
- plus $356 from 9 others
What the payments were for
- Food & beverage$2,356100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $541 |
| Supernus Pharmaceuticals, Inc. | 36 | $462 |
| Otsuka America Pharmaceutical, Inc. | 21 | $453 |
| Alkermes, Inc. | 9 | $198 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $183 |
| Teva Pharmaceuticals USA, Inc. | 8 | $164 |
| Corium, LLC | 3 | $71 |
| E.r. Squibb & Sons, L.L.C. | 3 | $69 |
| Neurocrine Biosciences, Inc. | 4 | $58 |
| Lundbeck LLC | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,356 in reported general payments places this provider in the 70th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 15 | $1,676 |
| Gabapentin | 14 | $417 |
| Buspirone Hcl | 24 | $372 |
| Quetiapine Fumarate | 13 | $296 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $196 |
| Sertraline Hcl | 26 | $160 |
| Lamotrigine | 11 | $131 |
| Mirtazapine | 12 | $78 |
| Alprazolam | 23 | $59 |
| Trazodone Hcl | 24 | $59 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Saint Louis
- Aldijana SacicSaint Louis$510K
- Julie WaterburySaint Louis$135K
- Melinda SmithSaint Louis$13K
- Richard YakimoSaint Louis$10K
- Yevgeniya MykhaylevskaSaint Louis$9K
- Anastasia AmiramovaSaint Louis$9K
- Jessica BurichSaint Louis$8K
- Jennifer ArmstrongSaint Louis$8K
- Bonnie HuffSaint Louis$7K
- Jacqueline KirkSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.